Speaker illustration

Doctor Clare Proudfoot

Novartis Pharma AG, Basel (Switzerland)

Patients with heart failure and a LVEF less than 40% present an overall lower health related quality of life than those with LVEF between 40% and 60%: a multinational real-world survey in EU

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure ePosters


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb